There are 2789 resources available
467P - Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
Presenter: Eleonora Lai
Session: ePoster Display
468P - Prognostic role of aspartate aminotransferase-to-alanine aminotransferase ratio and lactate dehydrogenase levels in resectable colorectal cancer
Presenter: Ma Yifei
Session: ePoster Display
469P - Potential emergent role of liquid biopsy in clinical practice in metastatic colorectal cancer (mCRC) treatment
Presenter: Valeria Zurlo
Session: ePoster Display
Resources:
Abstract
470P - Genomic landscape and its correlations with immunotherapy-related biomarkers in Chinese colorectal cancer patients
Presenter: Xiao Zheng
Session: ePoster Display
Resources:
Abstract
471P - Prognostic role of preoperative direct bilirubin-to-indirect bilirubin ratio and neutrophils-to-lymphocytes in resectable colorectal cancer
Presenter: Yifei Ma
Session: ePoster Display
472P - Characterizing the anal microbiome in proximal versus distal colorectal cancer
Presenter: Soham Ali
Session: ePoster Display
473P - A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)
Presenter: Akihito Kawazoe
Session: ePoster Display
335TiP - Open-label, multinational, multicenter, phase IIIb/IV study of trastuzumab deruxtecan (T-DXd) in patients with or without baseline brain metastasis with previously treated advanced/metastatic human epidermal growth factor receptor 2–positive breast cancer (HER2+ BC): DESTINY-Breast12
Presenter: Nancy Lin
Session: ePoster Display
336TiP - Ipatasertib plus non-taxane chemotherapy for metastatic triple-negative breast cancer (TNBC): Pathfinder trial
Presenter: Antonio Llombart Cussac
Session: ePoster Display
337TiP - An open-label, phase Ib/II study to evaluate the safety and efficacy of fruquintinib in combination with tislelizumab in patients with advanced triple-negative breast cancer
Presenter: Debu Tripathy
Session: ePoster Display